{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:34:26Z","timestamp":1776756866198,"version":"3.51.2"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cal Wenzel Chair in Hepatology"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193960","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T13:26:32Z","timestamp":1521465992000},"page":"e0193960","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS)"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-9675","authenticated-orcid":true,"given":"Henry H.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel Aziz","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellina","family":"Lytvyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan J.","family":"Urbanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark G.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,3,19]]},"reference":[{"issue":"Suppl 2","key":"ref1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000440831","article-title":"Overlap Syndromes","volume":"33","author":"O Chazouill\u00e8res","year":"2015","journal-title":"Dig Dis Basel Switz"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-015-8516-5","article-title":"The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis","volume":"50","author":"F Yang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"MG Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"O Chazouill\u00e8res","year":"1998","journal-title":"Hepatol Baltim Md"},{"key":"ref5","first-page":"148","article-title":"A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinations","volume":"10","author":"H Zhang","year":"2015","journal-title":"Przegl\u0105d Gastroenterol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"44","author":"O Chazouill\u00e8res","year":"2006","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"P Muratori","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1155\/2012\/890698","article-title":"Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases","volume":"26","author":"T Himoto","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"KD Lindor","year":"2009","journal-title":"Hepatol Baltim Md"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"S Joshi","year":"2002","journal-title":"Hepatol Baltim Md"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"KM Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"ref13","article-title":"Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies","author":"M Infantino","year":"2015","journal-title":"Journal of Immunology Research"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/03009747509095624","article-title":"Detection of antibodies to DNA by radioimmunoassay and immunofluorescence","volume":"11","author":"LA Aarden","year":"1975","journal-title":"Scand J Rheumatol Suppl"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/art.1780200308","article-title":"An immunofluorescent method using Crithidia luciliae to detect antibodies to double-stranded DNA","volume":"20","author":"W Crowe","year":"1977","journal-title":"Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrrheum.2015.151","article-title":"Anti-DNA antibodies\u2014quintessential biomarkers of SLE","volume":"12","author":"DS Pisetsky","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pt.2012.11.005","article-title":"Dual core processing: MRB1 is an emerging kinetoplast RNA editing complex","volume":"29","author":"H Hashimi","year":"2013","journal-title":"Trends Parasitol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00294-005-0027-0","article-title":"Unexplained complexity of the mitochondrial genome and transcriptome in kinetoplastid flagellates","volume":"48","author":"J Lukes","year":"2005","journal-title":"Curr Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/EC.3.2.518-526.2004","article-title":"Mitochondrial histone-like DNA-binding proteins are essential for normal cell growth and mitochondrial function in Crithidia fasciculata","volume":"3","author":"NK Avliyakulov","year":"2004","journal-title":"Eukaryot Cell"},{"key":"ref20","first-page":"642","article-title":"Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis","volume":"35","author":"GL Norman","year":"2015","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1200\/JCO.2012.44.0412","article-title":"Targeting Mutant p53 in Human Tumors","volume":"30","author":"BD Lehmann","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/0891693021000054075","article-title":"Prevalence of autoantibodies to the p53 protein in autoimmune hepatitis","volume":"35","author":"J Herkel","year":"2002","journal-title":"Autoimmunity"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","article-title":"Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis","volume":"33","author":"M Volkmann","year":"2001","journal-title":"Hepatol Baltim Md"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"M Manns","year":"1987","journal-title":"Lancet Lond Engl"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"MP Manns","year":"2010","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: Autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"K Zachou","year":"2004","journal-title":"J Autoimmune Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2007.07.016","article-title":"Clinical and serological features of patients with autoantibodies to GW\/P bodies","volume":"125","author":"RA Bhanji","year":"2007","journal-title":"Clin Immunol Orlando Fla"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2249.2010.04288.x","article-title":"Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis","volume":"163","author":"LM Stinton","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1261\/rna.5810203","article-title":"The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies","volume":"9","author":"T Eystathioy","year":"2003","journal-title":"RNA N Y N"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1261\/rna.2142405","article-title":"Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body","volume":"11","author":"JH Yu","year":"2005","journal-title":"RNA N Y N"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"S Itoh","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"J Wesierska-Gadek","year":"2006","journal-title":"Hepatol Baltim Md"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"M Nakamura","year":"2007","journal-title":"Hepatol Baltim Md"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3748\/wjg.v20.i10.2606","article-title":"Autoantibodies in primary biliary cirrhosis: Recent progress in research on the pathogenetic and clinical significance","volume":"20","author":"S Yamagiwa","year":"2014","journal-title":"World J Gastroenterol WJG"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5387\/fms.58.107","article-title":"Autoantibodies by line immunoassay in patients with primary biliary cirrhosis","volume":"58","author":"H Saito","year":"2012","journal-title":"Fukushima J Med Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"S355","DOI":"10.1016\/S0168-8278(17)31049-8","article-title":"FRI-375\u2014The novel hexokinase 1 antibodies are useful for the diagnosis and associated with bad prognosis in primary biliary cholangitis","volume":"66","author":"A Reig","year":"2017","journal-title":"J Hepatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1155\/2010\/431913","article-title":"Autoantibodies and liver disease: Uses and abuses","volume":"24","author":"MV Zeman","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3748\/wjg.v16.i4.453","article-title":"Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease","volume":"16","author":"RK Moreira","year":"2010","journal-title":"World J Gastroenterol WJG"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"AJ Czaja","year":"2002","journal-title":"Hepatol Baltim Md"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e000158","DOI":"10.1136\/bmjgast-2017-000158","article-title":"Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona","volume":"4","author":"S Tan","year":"2017","journal-title":"BMJ Open Gastroenterol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T08:53:37Z","timestamp":1540284817000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193960"}},"subtitle":[],"editor":[{"given":"Gianfranco D.","family":"Alpini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,19]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193960","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,19]]}}}